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Abstract: Atrial fibrillation (AF) is the most common
clinically significant arrhythmia and is associated with
considerable increase in morbidity and mortality. Its
appropriate evaluation and management are therefore of
paramount importance. Cardiac imaging plays a crucial
role in this regard. Imaging permits the identification of
cardiovascular conditions that predispose to the develop-
ment and perpetuation of AF. Furthermore, imaging
provides important information to refine strategies to
prevent thromboembolic complications of the arrhythmia
and allows characterization of the arrhythmogenic sub-
strate itself. This capacity places imaging in a pivotal
position in the workup and treatment of AF. This review
provides a critical appraisal of the role of currently
available imaging techniques for evaluating patients with
AF. In addition, the importance of imaging in guiding AF
therapy with respect to the prescription of anticoagula-
tion, cardioversion, and radiofrequency catheter ablation
techniques are summarized. (Curr Probl Cardiol 2012;
37:7-33.)A trial fibrillation (AF) is the most common clinically significantarrhythmia, occurring in 1%-2% of the general population.1 The
lifetime risk for the development of AF in the Framingham cohort
as 25% among those aged over 40 years.2 In addition, among individ-
als in Western Europe aged 55 years and above, the prevalence of AF is
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8.5%.3 The clinical consequences of AF are well known and include
ncreased risk of death, stroke, other thromboembolic complications, and
eart failure.4 Aging is one of the most important risk factors for
eveloping AF. The incidence of AF increases with advancing age to 9.7
er 1000 person-years among those aged over 70 years.5 In addition,
hronic cardiovascular diseases, such as hypertension and ischemic and
alvular heart disease, carry an increased risk of AF and modify the
rrhythmogenic substrate favoring perpetuation of this arrhythmia.6,7
herefore, aging populations and improved survival of individuals with
hronic diseases are likely to contribute to a greater burden of disease
ttributable to AF in the future.
The increased morbidity and mortality associated with AF has promoted
ngoing research to understand the underlying mechanisms of this
rrhythmia and to develop effective therapies.1,8 Recent developments in
troke prevention and new approaches in antiarrhythmic therapy have
nfluenced the clinical management of patients with AF, which has been
ocused on the prevention of AF-related complications, control of
entricular rate, and treatment of concomitant cardiac disease.1
Cardiac imaging plays a pivotal role in the evaluation and management
f AF (Fig 1). Imaging permits the identification of conditions that
redispose to the development and perpetuation of AF, such as left
entricular (LV) dysfunction or valvular heart disease. Furthermore,
maging provides important information to refine stroke prevention
trategies and permits characterization of the arrhythmogenic substrate
hat may lead to improved outcome of specific AF therapies, such as
adiofrequency catheter ablation (RFCA) procedures. Table 1 summarizes
he role of noninvasive imaging techniques in the evaluation of AF
atients.
This review provides a critical appraisal of the role of currently
vailable imaging techniques for evaluating patients with AF. The
mportance of imaging in characterizing pathologic left atrial (LA)
ubstrate and comorbid conditions (structural heart disease) underlying
his arrhythmia is described. In addition, the role of imaging in guiding
F therapy with respect to the prescription of anticoagulation, cardiover-
ion, and RFCA techniques is summarized.
ormal Left Atrial Structure and Function
Structural remodeling of the LA, including dilatation of the LA
estibule or the pulmonary veins, has been related to the presence of AF.9
n addition, LA structural remodeling has been linked to LA dysfunction
Curr Probl Cardiol, January 2012
t
c
i
f
F
A
o
S
a
T
A
A
E
R
A
r
c
*
A
Chat may further increase the risk of atrial arrhythmias. Therefore,
haracterization of the anatomy, geometry, and function of the LA with
maging techniques may help to understand the pathophysiological
IG 1. Flow diagram illustrating the role of cardiac imaging in the evaluation and treatment of
F. Adapted with permission from Camm et al. Figure 3 from Guidelines for the management
f atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European
ociety of Cardiology (ESC) Eur Heart J (2010) 31(19): 2369-2429.1 LA, left atrial; LASEC, left
trial spontaneous echocardiographic contrast. (Color version of figure is available online.)
ABLE 1. Role of different imaging modalities in patients with AF
Role
Imaging modality
TTE TEE CMR MDCT Nuclear imaging
ssessment of LA size     —
ssessment of LA function     —
valuation of underlying heart disease
Valvular heart disease     —
Coronary artery disease  —   
Hypertensive heart disease  —   —
Congestive heart failure  —   
Identification of LA thrombus —    —
FCA procedures
Preablation     —
Intra-ablation* —  — — —
Postablation  —  — —
bbreviations: CMR, cardiovascular magnetic resonance; LA, left atrial; MDCT, multidetector
ow computed tomography; RFCA, radiofrequency catheter ablation; TTE, transthoracic echo-
ardiography; TEE, transesophageal echocardiography.
Intracardiac echocardiography is a novel echocardiographic modality that may be used during
F catheter ablation.actors underlying this arrhythmia.
urr Probl Cardiol, January 2012 9
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1The LA is separated from the right atrium by the interatrial septum. This
tructure comprises the foramen ovale—a flap valve formed by an inferior
uscular rim, the infolded right atrial wall superiorly, and a “fibrofatty
andwich of atrial and ventricular musculature” anteriorly.10 In most
ases, 2 pulmonary veins from each lung drain into the LA at the atrial
oof (Fig 2). Common pulmonary vein ostia or extrapulmonary veins may
e observed as normal variants.10 In addition, at the anterior wall of the
IG 2. left atrial (LA) anatomy correlates with noninvasive imaging. (A) Longitudinal section
hrough the heart that permits visualization of the interatrial septum from the LA. The black arrow
ndicates the crescentic edge of the fossa ovalis. On 3-dimensional TEE (B), these anatomical
etails can be noted together with the surrounding structures, such as the RSPV, the mitral valve,
nd the CS. The anterior wall of the LA is displayed in (C). The aortic root is retracted forward
nd the right and left atrial appendages (LAAs) are deflected laterally. The BB is located at the
nteratrial groove and the curved arrows indicate the bifurcations of this bundle as it
pproaches the appendages. The dotted line indicates the “unprotected” LA wall. The imaging
orrelate of these structures can be appreciated with MDCT (D). The aortic root is colored red.
he LA is located posteriorly. MDCT provides superior image quality and permits identification
f the pulmonary veins, LAA, right atrial appendage, and the SVC. (Adapted with permis-
ion.84). Ao, aorta; BB, Bachmann’s bundle; CS, coronary sinus; LAA, left atrial appendage;
IPV, left interior pulmonary vein; LSVP/LS, left superior pulmonary vein; RAA, right atrial
ppendage; RIPV, right inferior pulmonary vein; RSPV/RS, right superior pulmonary vein; SVC,
uperior vena cava. (Color version of figure is available online.)A, the Bachmann’s bundle is located, close to the sinoatrial node at
0 Curr Probl Cardiol, January 2012
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Che insertion of the crista terminalis into the atrial roof and anterior to the
uperior vena caval ostium (Fig 2). Electrical depolarization of the LA
ccurs normally via this muscular tract that links the left and right atria.
hese communicating fibers may also be found at the anterior margin of
he foramen ovale.
The LA appendage (LAA) is a narrow, blind-ended structure arising
rom the LA free wall, protruding superiorly and leftward. The LAA is
ultilobed in 80% of cases11 and features pectinate muscles within it (Fig
). These structures may be differentiated from LAA thrombus by their
inear appearance. In addition, assessment of the spatial relationships of
he LAA is important before percutaneous closure interventions of this
tructure. The LAA lies in close relation to the ostium of the left superior
ulmonary vein, from which it is separated by a ridge. The LAA is also
n proximity to the left circumflex coronary artery within the atrioven-
ricular groove (Fig 3).
Current 3-dimensional imaging techniques, such as 3-dimensional
ransesophageal echocardiography (TEE), multidetector row computed
omography (MDCT), and cardiac magnetic resonance (CMR), provide
robably the most accurate approach to assess these anatomical aspects
nd are important tools to guide transcatheter-based therapies.
Furthermore, changes in the dimensions of the LA are important
arkers of LA structural remodeling and changes in the arrhythmogenic
ubstrate. LA dimensions and structure are commonly assessed with
ransthoracic echocardiography (TTE) or TEE. LA volume may be
stimated from 2-dimensional TTE by the modified Simpson’s method,
he area-length technique, or the prolate ellipsoid approach (Fig 4).
owever, 2-dimensional imaging techniques may lack accuracy by
ntroducing geometric assumptions in the calculation of the LA dimen-
ions. In contrast, 3-dimensional imaging techniques, such as real-time
-dimensional TTE, MDCT, and CMR, may provide more exact and
etailed assessment of the dimensions, structure, and spatial relationships
f the LA, crucial for risk stratification and clinical decision-making of
atients with AF (Fig 5).
Several imaging modalities have been proposed to assess LA function,
hich may be divided into 3 phases: reservoir, conduit, and contractile
hase. Phasic changes in LA volume may be measured with TTE, CMR,
r MDCT12-14 (Fig 6). The reservoir function, which reflects LA filling
uring LV systole, may be evaluated by the difference between its
aximal volume (at LV end-systole, 1 frame before mitral valve opening)
nd its minimal volume (at LV end-diastole) and expressed as a
ercentage of minimal LA volume. The conduit function is assessed by
urr Probl Cardiol, January 2012 11
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1he difference between maximal LA volume at LV end-systole and its
olume at the onset of atrial contraction (marked by the P-wave on the
lectrocardiogram) and can be expressed as a percentage of maximal LA
olume. Finally, the contractile function is evaluated by calculating the
ifference between LA volume at the onset of atrial contraction and its
inimum volume at LV end-diastole and can be expressed as a percent-
IG 3. Visualization of the left atrial appendage (LAA) with noninvasive imaging techniques. (A)
natomical section through the ostium (OS) of the LAA (double arrowhead). The spatial
elationship of the LAA with the circumflex coronary artery (Cx), left pulmonary veins (superior
LSPV] and inferior [LIPV]), and mitral valve can be visualized. On 2-dimensional TEE (B), a
5°-60° midesophageal view permits visualization of the long axis of the LAA and the
elationship with the circumflex coronary artery, the left superior pulmonary vein, and the ridge
hat separates them. The pectinate muscles are located within the body of the LAA (arrows).
ith 3-dimensional TEE, the exact relationship between the LAA and the left superior pulmonary
ein can be visualized. (D) Longitudinal section of the heart through the ridge (black arrow) and
he pointed profile of this structure formed by the infolding of the atrial wall. MDCT
econstructions provide accurate evaluation of these structures. (E) Longitudinal section of the
eart visualized with MDCT. The left superior pulmonary vein is separated by the ridge from the
AA. The circumflex coronary artery is in close relationship with the left appendage and the mitral
nnulus. (Adapted with permission.84,85) CS, coronary sinus; Cx, circumflex coronary artery; LAA,
eft atrial appendage; LIPV/LI, left interior pulmonary vein; LSVP/LS, left superior pulmonary vein;
S, ostium. (Color version of figure is available online.)ge of its volume at the onset of atrial contraction.
2 Curr Probl Cardiol, January 2012
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CEchocardiographic techniques have provided various LA function
ndexes. Pulse-wave Doppler echocardiography at the tips of the
itral valve leaflets and at the pulmonary vein ostia provides
nformation on hemodynamics between the LA and LV, and upstream
o the LA, respectively. Measurement of the peak transmitral A-wave
elocity and velocity-time integral in late diastole with pulsed-wave
oppler echocardiography has been used as indexes of LA function
Fig 7). In addition, the ratio between peak transmitral E-wave
elocity and peak septal mitral annular tissue velocity in early diastole
the E/E= ratio) has been well validated as a noninvasive measure of
V filling pressure, a parameter that reflects indirectly the pressure
verload of the LA. More novel indexes for the assessment of LA
unction include measurement of late diastolic tissue velocity at the
eptal mitral annulus (A= velocity), LA strain (or deformation), and
train rate (Fig 7). These parameters may be measured by either tissue
oppler techniques or speckle tracking echocardiography and provide
irect information of LA myocardial properties.
These various methods of evaluation of LA structure, dimensions, and
unction have all been engaged in the assessment of patients with AF. The
ollowing text expands on the application of cardiovascular imaging to
he clinical setting.
asood Akhtar: The authors do an excellent job of describing the anatomy
IG 4. Assessment of left atrial dimensions. Two-dimensional techniques for estimating LA linear
iameters and volume,86 where L is the longer of L1 and L2, and A2CH and A4CH are the areas
f the atrium traced at end-ventricular systole in the apical 2- and 4-chamber views, respectively,
nd h is the disk height. A, parasternal long axis view; B, apical 4-chamber view; C, apical
-chamber view. (Color version of figure is available online.)nd various structures that help to guide electrophysiologists to identify
urr Probl Cardiol, January 2012 13
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1IG 5. Three-dimensional techniques for the evaluation of left atrial size and geometry. (A)
epresentative short-axis cine cardiac magnetic resonance image at the level of the left atrium
t end-ventricular systole. LA volume may be estimated by summation of the volumes of
ontiguous slices spanning the left atrium. (B-E) Cropped 3-dimensional transthoracic echocar-
iography data set. The left atrium is demonstrated in the 4-chamber (B), 2-chamber (C),
hort-axis (D) views, and as a sliced 3-dimensional image (E). A volume-rendered computed
omography image of the left atrium and pulmonary veins is displayed in (F), with orthogonal
ections through the left atrium in the 4-chamber (G), 2-chamber (H), and short axis (I) views.
o, aorta; LA, left atrium; LIPV, left inferior pulmonary vein; LSPV, left superior pulmonary vein;
V, left ventricle; PA, pulmonary artery; RA, right atrium; RIPV, right inferior pulmonary vein;
SPV, right superior pulmonary vein. (Color version of figure is available online.)
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Candmarks and their role, if any. When it comes to function, however, only the
eft atrium as a whole is addressed. For example, I did not learn much about
he function of LAA. Maybe the expression of role rather than function will
escribe what is presented here more accurately.
valuation of Conditions Predisposing to Atrial
ibrillation
AF frequently coexists with other cardiac conditions, such as coronary
IG 6. Graphical representation of phasic changes in LA volume during the cardiac cycle.
Adapted with permission.14) (See text for elaboration.)
IG 7. Transthoracic echocardiographic techniques for evaluating LA function. (A) Tissue
oppler imaging of the septal mitral annulus, with A= indicated (blue arrows). (B) Speckle-
racking strain of the left atrium, with dotted curve representing the average of 6 segments and
he yellow arrow indicating the peak strain. (C) Strain rate of the left atrium by tissue Doppler
maging (white arrows). (Color version of figure is available online.)rtery disease (CAD) or valvular heart disease. The recognition and
urr Probl Cardiol, January 2012 15
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1ppropriate treatment of such conditions may halt or reverse LA remod-
ling and thus ameliorate AF and prevent progression of the arrhythmia
o sustained forms of AF. Cardiac imaging plays a pivotal role in the
iagnosis and evaluation of these various comorbidities that predispose to
F. TTE is the imaging modality most commonly employed for the initial
valuation of individuals presenting with AF, owing to its versatility,
afety, and ability to assess myocardial and valvular structure and
unction. CMR, MDCT, and radionuclide techniques offer information
hat is complementary to TTE and may be useful in the evaluation of the
onditions described subsequently.
alvular Heart Disease
Valvular heart disease is observed in approximately 1 in 5 first-detected
ases of AF.15 Mitral valve disease may promote LA dilatation directly
hrough the volume or pressure load presented to the LA. Longstanding
ortic stenosis results in LV hypertrophy, myocardial fibrosis, and
iastolic dysfunction, which impose a pressure load on the LA. Because
f high temporal resolution, both 2-dimensional and Doppler echocardio-
raphic techniques are well suited to the identification and quantification
f valvular heart disease.16 In addition, CMR is a comprehensive imaging
odality used to assess valvular morphology and function and hemody-
amic consequences of valvular dysfunction with LV and LA volumes
easurement and tissue characterization.17 Steady-state free precession
ine CMR sequences are commonly used for morphologic and functional
valuation of cardiac structures, whereas velocity-encoded phase imaging
ermits accurate assessment of blood flow. Instantaneous flow velocities
cross the cardiac valve can be measured with “through-plane” sequences
nd integration of these velocities along the cardiac cycle provides flow
olume per heart beat. Furthermore, separate analysis in systole and
iastole permits calculation of forward and regurgitant volumes.18
oronary Artery Disease
In patients with AF, a high prevalence of CAD is reported.19 Among
ndividuals with first-presentation AF and no past history of ischemic
eart disease, the subsequent incidence of coronary events was 31 per
000 person-years.20 CAD should therefore be excluded in new-presen-
ation AF unless the pretest probability is low. Noninvasive imaging
odalities permit direct evaluation of the luminal narrowing of the
oronary arteries (anatomical imaging) or assessment of the hemody-
amic consequences of obstructive CAD (functional imaging).
6 Curr Probl Cardiol, January 2012
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CThe high negative-predictive value of MDCT for detection of signifi-
ant CAD makes this imaging technique a valuable gatekeeper for
nvasive coronary angiography.21,22 It is the noninvasive imaging modal-
ty of choice for the detection of coronary atherosclerosis in populations
ith low or intermediate risk for CAD and provides information on
laque burden, composition and positive arterial remodeling. In addition,
echnological advances have improved the accuracy of CMR to charac-
erise coronary atherosclerotic plaques.23
Furthermore, CMR imaging, single-photon emission computed tomog-
aphy, positron emission tomography, and stress echocardiography are
he imaging modalities to evaluate the functional consequences of
bstructive CAD (myocardial ischemia). The sensitivity and specificity of
hese imaging modalities to detect obstructive CAD are between 80% and
0%.24
Although all noninvasive cardiac imaging techniques have demon-
trated utility in the identification of ischemic heart disease, the choice of
pproach adopted should be individualized and also guided by local
xpertise. In addition, there is growing evidence that sequential or
ombined noninvasive imaging techniques may provide complementary
nformation along the ischemic cascade in the evaluation of patients for
AD.25
ypertensive Heart Disease
Hypertension has long been recognized as an independent risk factor for
he development of AF.26 The mechanisms by which hypertension causes
F are complex and may involve neurohormonal changes, LV diastolic
ysfunction and hypertrophy, LA distension, fibrosis, and associated
lectrophysiological abnormalities.
Diastolic LV dysfunction may be the earliest manifestation of hyper-
ensive heart disease, preceding morphologic changes that result from
rolonged hypertension. TTE is the modality of choice for the evaluation
f diastolic LV function. Three-dimensional imaging techniques, such as
MR, MDCT, and 3-dimensional echocardiography, can offer evidence
o support the diagnosis of hypertensive heart disease through accurate
easurement of LA volume and LV mass.27
eart Failure
Congestive heart failure is among the most potent risk factors for the
evelopment of AF.26 The pathophysiological mechanisms linking LV
ysfunction and AF share some common ground with hypertensive heart
isease.
urr Probl Cardiol, January 2012 17
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1Two-dimensional TTE remains the mainstay of evaluation of systolic
V function in clinical practice. In addition, tissue Doppler imaging,
train imaging, contrast echocardiography, and 3-dimensional echocardi-
graphy have provided important information on LV hemodynamics and
echanics. Notably, global LV longitudinal and circumferential strain by
peckle tracking echocardiography incorporate characterization of the LV
yocardium in addition to the evaluation of contractile function28 and
ave been shown to confer additive prognostic value to conventional
chocardiographic parameters.29,30
CMR is now regarded as the noninvasive gold standard in the
uantification of LV volumes, ejection fraction, and mass, owing to its
igh spatial resolution and signal-to-noise ratio, and its 3-dimensional
ature. It is a highly reproducible technique for the evaluation of systolic
V function and for the identification of LV remodeling.
In summary, although TTE is indicated in the initial workup of patients
resenting with AF for the first time,31 further imaging may be useful in
he evaluation of underlying myocardial, valvular, or coronary artery
isease. The choice of modality in these circumstances must be individ-
alized and should also be guided by local expertise.
asood Akhtar: The exact part played by these so-called predisposing
actors, particularly CAD, is not clear. It is also not proven, for instance, that
F will be abolished if CAD was found and fixed. Although CAD may cause
ubclinical atrial damage/fibrosis, coexistence of CAD and AF may simply be
ue to a high prevalence of both in a given population. Valvular disease,
ypertension, atrial stretch, and dilatation predisposing to AF are more
onvincing and already well accepted. I wonder if the authors have any
ypothesis as to what predisposes patients to the so-called lone AF.
maging to Understand the Mechanisms
nderlying AF and Thromboembolism
Cardiac imaging has been a cardinal tool in the examination of the
echanisms that underlie AF and its complication, thromboembolism.
A remodeling refers to “changes in atrial properties and function that
romote AF.”32 These changes include ion channel remodeling, cellular
icroscopic changes, and macroscopic remodeling on both structural and
unctional level.
LA dilatation is clearly associated with the development of AF. In a
opulation-based study, Vaziri et al found an increase in LA size to be an
ndependent predictor of the subsequent risk of occurrence of AF.33 The
8 Curr Probl Cardiol, January 2012
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Cole of AF itself in causing LA dilatation and stretch, which may then
romote further AF, has long been recognized using cardiac imaging.34
ore recent experimental evidence from a canine model of AF suggests
hat the arrhythmia itself may cause atrial fibrosis.35 As will be subse-
uently expanded on, there are emerging imaging approaches for the
dentification and quantification of LA fibrosis.36,37 Cardiac imaging
echniques, such as CMR and MDCT, that permit visualization of
eriatrial structures have drawn attention to the potential role of periatrial
at in the pathogenesis of AF.38,39
Thromboembolism in AF is a complex pathophysiological process with
iverse etiological factors. Adverse LA remodeling and mechanical
ysfunction have been implicated in the prothrombotic milieu. The
elationship between these factors and LA thrombosis or clinical throm-
oembolism has been reported using TEE. Fatkin et al showed that the
easurement of LA spontaneous echocardiographic contrast and LAA
mptying velocity are closely related to the presence of LA thrombus in
atients with AF.40 The LAA has been implicated as the most common
A source of thrombus.41 Therefore, there has been great research interest
n the value of closing this structure to prevent the development of
hrombus there.42,43 Pre- and intraprocedural imaging to define patient
uitability for LAA closure and to guide the procedure are likely to play
mportant roles in the advancement of this therapeutic alternative to
nticoagulation.44
maging in AF Treatment: Guiding Anticoagulation
The decision to recommend anticoagulation for the prevention of
hromboembolic complications in the individual with AF demands an
nderstanding of the risks and benefits of anticoagulation vs the degree of
hromboembolic risk. In the clinical setting, evaluation of thromboem-
olic risk is most frequently performed by scoring systems, such as the
ongestive heart failure, hypertension, age, diabetes, CHADS2 score.45
hese clinical aids may only have limited discriminatory ability, how-
ver.46 There is emerging evidence that cardiac imaging may further
efine such risk prediction strategies. In a study of AF patients who had
ndergone TEE, Kamp et al demonstrated that LAA emptying velocity
20 cm/s was an independent predictor of future thromboembolic
vents.47 In research illustrating how the findings of these studies might
e incorporated in a clinical practice framework, Thambidorai et al have
hown that TTE and TEE added incremental predictive value for the
ombined endpoint of LA thrombus and clinical thromboembolism,
espectively.48 Although most work on the identification of high-risk
urr Probl Cardiol, January 2012 19
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2haracteristics for subsequent thromboembolism has employed echocar-
iographic imaging, complementary imaging techniques may offer par-
icular advantages in this regard. For instance, using CMR, Beinart et al
emonstrated that LAA dimensions are an independent predictor of stroke
mong patients with AF.49
Although noninvasive imaging to refine thromboembolic risk prediction
n AF is appealing, its role in clinical practice remains to be defined in
dequately sized cohorts or a randomized trial.
asood Akhtar: This section on thromboembolism in AF is fairly well
overed by the authors. Although TTE and TEE have been the usual tools for
etection of atrial thrombus, the added tools, such as LA emptying velocity
nd CMR, provide additional and independent predictive information. The
uestion arises that, if early and precise diagnosis of soft LA thrombus is
ade with newer technologies, would it change our management approach
rom the routine long-term anticoagulation to intervention to prevent impend-
ng embolization and then start anticoagulation?
maging in AF Treatment: Guiding Cardioversion
Before electrical cardioversion, detection of intracardiac thrombus is the
ain indication of cardiac imaging. In contrast, after electrical cardio-
ersion, recovery of LA function and monitoring of LA remodeling are
he main focus of imaging modalities.
TEE has a well-established role in the exclusion of LA thrombus before
F cardioversion. In a randomized, multicenter study comparing TEE-
uided cardioversion to cardioversion following 3 weeks of anticoagula-
ion, the TEE-guided strategy proved at least as clinically effective as the
onimaging approach.50
There is also evidence to suggest that LA imaging may offer predictive
alue in the identification of individuals in whom cardioversion is likely
o offer long-term freedom from AF. The measurement of LAA emptying
elocity by TEE has been shown to be an important predictor of
ong-term freedom from AF recurrence following cardioversion.51 Novel
chocardiographic techniques evaluating the function of the LA myocar-
ial wall have been shown to predict AF recurrences after successful
ardioversion. Dell’Era et al evaluated the LA mechanical properties with
peckle tracking echocardiography in patients undergoing cardioversion
f persistent AF.52 These investigators reported significant functional LA
emodeling following successful cardioversion and improvement in LA
unction reflected by an increase in LA strain. In addition, LA synchrony
0 Curr Probl Cardiol, January 2012
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Cs measured with speckle tracking echocardiography was predictive of
reedom from AF at 1-year follow-up.
After electrical cardioversion, imaging studies have clearly demonstrated
he occurrence of stunning–transient LA mechanical dysfunction.53,54 This
henomenon has been related to increased risk for thrombus formation
nd, accordingly, therapeutic anticoagulation is recommended for at least
weeks following cardioversion to prevent thromboembolism.1,55
homas et al examined the time course of recovery of LA mechanical
unction following cardioversion using transmitral A-wave velocity as an
ndex of LA contractility.56 Improvements in LA mechanical function
ere reported at 4 weeks after successful cardioversion, thus providing
echanistic support for the observation of elevated thromboembolic risk
uring this postcardioversion period.57
maging in AF Treatment: Precatheter Ablation
In AF patients who are candidates for RFCA techniques, cardiac
maging plays a central role before, during, and after this therapeutic
pproach. These procedures aim to electrically isolate pulmonary veins
rom the LA. The reported efficacy of these procedures in patients with
aroxysmal AF is approximately 70%.58 Despite the largely proven safety
f pulmonary vein isolation procedures, the 3%-5% overall complication
ate indicates that accurate selection and evaluation of candidates for
hese procedures are mandatory. In this regard, cardiac imaging plays a
ivotal role.
TTE may serve to identify AF patients who are less likely to
xperience a favorable response to catheter ablation. Among patients
ith persistent AF, McCready et al found LA size to be the sole
ndependent predictor of AF recurrence.59 Using tissue Doppler-
erived strain, Tops et al have shown an independent, positive
elationship between baseline LA mechanical deformation and subse-
uent reverse structural LA remodeling as a surrogate for procedural
fficacy following AF ablation.60 The authors speculate that degree of
A deformation may reflect the underlying extent of LA fibrosis,
hich is likely to be a determinant of the ability of the left atrium to
everse remodel after successful RFCA.
In addition to the measurement of LA size, which as previously
iscussed may be predictive of AF ablation success, MDCT offers
mportant anatomical information before the ablation procedure. There is
onsiderable variation in LA and pulmonary vein geometry, and pulmo-
ary vein number, among both patients with AF and healthy individu-
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2ls.61 With its high spatial resolution, MDCT is well suited to illustrate
hese variants and guide the approach undertaken to ablation.62,63
asood Akhtar: Significant variations in anatomy can be seen in the left
trium. In a recent study (Preliminary results: 96 Radiological Society of
orth-America scientific assembly 2010: Abstract SSJ 05-01; published
nline December 3, 2010), image processing and analysis were performed on
15 consecutive patients (74.8% male, median age 58, range 51-66 years)
ith AF and CT scans performed before LA ablation. Most patients’ LA
natomies fell into 1 of 3 categories. Patients with 2 left pulmonary veins and
right pulmonary veins were, not unexpectedly, the most common with 332
atients (64.5%). Patients with 2 left pulmonary veins and 3 right pulmonary
eins were the next most commonly seen type with 90 patients (17.5%). Also
een commonly were patients with 1 left pulmonary veins and 2 right
ulmonary veins, 63 patients (12.2%). We observed 13 patients with 2 left
ulmonary veins and 4 right pulmonary veins (2.5%) and 9 with 1 left
ulmonary vein and 3 right pulmonary veins (1.7%) were also seen. Figure 1
hows examples of these. The remaining 8 (1.6%) patients showed less
ommon anatomical varieties, including 3 left pulmonary veins and 2 or 3
ight pulmonary veins, common right pulmonary veins, common inferior
ulmonary veins, etc.
Furthermore, CMR exhibits particular strengths in imaging the left
trium, particularly as part of the workup for AF ablation. As a
-dimensional modality with high spatial resolution and signal-to-noise
atio, CMR permits accurate measurement of LA volume.64 It is also able
o visualize the number and location of pulmonary veins. Indeed, in a
ead-to-head comparison of CMR with MDCT, Hamdan et al found close
greement between the 2 modalities in the evaluation of pulmonary vein
natomy and caliber.65
In addition, the capacity to characterize myocardial tissue with high
patial resolution is unique to CMR. Gadolinium-diethylenetriaminepenta
cetic acid (DTPA) is a paramagnetic contrast agent that has been used to
elineate areas of expanded extracellular space using CMR. The presence
f significant LA fibrosis as assessed with late-gadolinium enhancement
LGE-CMR) has been related with the outcomes of RFCA. In a study of
1 patients undergoing AF ablation, Oakes et al demonstrated the
easibility of LGE-CMR of the LA.36 Using a pixel intensity-based
hreshold technique to identify and quantify regions of LGE within the
A myocardium (Fig 8), these authors observed a close linear relationship
etween extent of LGE and atrial tissue voltage on electroanatomical
apping as a surrogate for myocardial fibrosis. Greater degree of baseline
A wall LGE (15%) was associated with an elevated odds of AFecurrence after catheter ablation (odds ratio 4.88, 95% confidence
2 Curr Probl Cardiol, January 2012
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Cnterval 1.73-13.74). Furthermore, Kuppahally et al extended these
ndings and showed that the presence of mild, rather than more extensive,
aseline LA LGE is associated with favorable structural and functional
everse remodeling after RFCA.66 In this study, LA remodeling was
valuated echocardiographically by measuring LA dimensions and LA
train and strain rate (using velocity vector imaging).
Finally, recent evidence implicates periatrial fat and its local effects in
he pathogenesis of AF. Using CMR to quantify periatrial fat, Wong et al
ave shown that its preablation burden is associated with AF recurrence
uring follow-up.67
maging in AF Treatment: During Catheter Ablation
Catheter ablation for AF involves the creation of lesions within the left
trium to disrupt the electrophysiological milieu responsible for the
evelopment of the arrhythmia. There exists considerable heterogeneity
IG 8. Delayed enhancement cardiac magnetic resonance of the left atrium to quantify
yocardial fibrosis. After CMR cropping, LA epicardium and endocardium are manually
lanimetered to create a region of interest. Areas of delayed enhancement are highlighted by
n algorithm on the basis of pixel intensity. (Reproduced with permission.36) Ao, aorta; LA, left
trium. (Color version of figure is available online.)n approaches described to perform AF ablation, including electrical
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2solation of the pulmonary veins from the LA body, ablation of complex
ractionated electrical signals, and other linear ablative strategies to create
ore extensive conduction block and substrate modification. Given the
forementioned variability in both LA anatomy and ablative techniques,
recise catheter navigation during the ablation procedure is critical to
nsure appropriate lesion delivery.
Guidance of AF ablation intraprocedurally is frequently performed by the
ntegration of 3-dimensional datasets (MDCT or CMR) acquired preproce-
urally with point-by-point electroanatomical mapping of the left atrium in
he electrophysiology laboratory. This approach to catheter guidance has
uperseded purely electroanatomic mapping systems in AF ablation owing to
he advantages that will be subsequently presented.68
Tops et al demonstrated the feasibility of fusion of MDCT and
lectroanatomic data to generate a 3-dimensional map to guide catheter
osition during AF ablation.69 This approach has been adopted to
emonstrate a reduction in intraprocedural fluoroscopy times and im-
roved outcomes over contact mapping techniques alone.70 Martinek et al
onfirmed these findings in a study of 100 AF patients undergoing
atheter ablation, in which integration of MDCT and electroanatomic data
ere associated with superior procedural success.71
Intracardiac echocardiography, in which the echocardiographic probe is
ositioned transvenously within the right atrium, has a well-established
ole in the intraprocedural guidance of transseptal puncture for AF
blation. In addition, preliminary research suggests a potential role for
-dimensional mapping of the LA using intracardiac echocardiography,
s a real-time accompaniment to preprocedural MDCT and intraproce-
ural electroanatomical mapping (Fig 9).72
Rotational angiography is an imaging approach to visualize LA anat-
my and surrounding structures that may be undertaken within the
lectrophysiology laboratory. Although experience with this technique is
imited, its development may overcome variation in LA dimensions
ttributable to differing loading conditions or atrial rhythm between
reprocedural scans and intraprocedural electroanatomical mapping.73
Current fluoroscopy-guided AF ablation may be associated with signif-
cant radiation exposure, for both the patient and the staff within the
lectrophysiology laboratory. There exists experimental evidence to
uggest the feasibility of CMR catheter guidance for ablation proce-
ures.74,75 This approach, although promising, has undergone limited
esting to date in humans and remains an area of potential advancement
n the field (Fig 10).
4 Curr Probl Cardiol, January 2012
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CIn addition to guidance of the ablation procedure, imaging plays a
rucial role in the identification and management of periprocedural
omplications. Cardiac perforation and tamponade are among the most
IG 9. Real-time integration of intracardiac echocardiography and MDCT to guide RFCA. The
A endocardial contours are traced in real-time (A) to obtain a 3-dimensional reconstruction of
he left atrium (B). In addition, the pulmonary veins are localized (C) and incorporated in the
olume rendering of the left atrium (D). Manual coregistration of the 3-dimensional LA volume
btained with intracardiac echocardiography and MDCT is performed to obtain the final 3-dimen-
ional rendering of the left atrium to guide the procedure (E). (Adapted with permission.72) Add PV,
dditional pulmonary vein; LCO, left common ostium; RIVP, right inferior pulmonary vein; RSPV,
ight superior pulmonary vein. (Color version of figure is available online.)
IG 10. Difference in visibility of (A) active (capable of receiving magnetic resonance signal)
nd (B) passive catheters on magnetic resonance images in a canine model. (Reproduced with
ermission.74)recipitous acute complications of AF ablation, and with a reported
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2ncidence of approximately 1%, are among the most common periproce-
ural adverse events.76 Owing to its portability and ability to guide
herapeutic pericardiocentesis in real-time, TTE serves a crucial role in
he identification and treatment of this adverse outcome.
maging in AF Treatment: Postcatheter Ablation
Cardiac imaging can fulfill 2 important roles following catheter ablation
or AF. It enables detection of late complications and the assessment of
tructural and functional outcomes of the ablation procedure on the left
trium.
Pulmonary vein stenosis is a complication that may develop either early
r late following AF ablation. In a multicenter survey, its incidence has
een reported in approximately 1.5% of patients undergoing ablation,76
lthough accurate estimation of its true frequency is hampered by
ariation in ablation technique and follow-up protocol. The severity of
ulmonary vein stenosis is frequently categorized according to anatomic
everity by MDCT, with mild stenosis defined as 50% luminal
arrowing, moderate stenosis 50%-69%, and severe stenosis 70%.77
lthough studies correlating these anatomic thresholds with their func-
ional (pulmonary venous flow velocity) consequence are scarce, success-
ul treatment of severe stenosis by these criteria appears effective at
eversal of patient symptoms.78 CMR is a theoretically attractive imaging
odality with which to detect and quantify pulmonary vein stenosis, as it
ay offer both anatomical and function information. Goo et al have
ecently demonstrated the feasibility of measuring pulmonary vein flow
elocity by phase contrast CMR.79 At the present time, however, the role
f CMR in evaluating this condition remains to be defined, particularly
iven the high spatial resolution of MDCT for measurement of pulmonary
ein caliber and the high temporal resolution of echocardiography to
dentify elevated flow velocities.
A reduction in LA size has been generally reported following AF
blation using heterogeneous ablation techniques and imaging modali-
ies.80,81 The exact mechanism underlying the observed reduction in LA
ize remains uncertain. Although some studies have found reduction in
A size only among those without recurrent AF,81 suggesting that the
rrhythmia itself promotes LA enlargement, others have reported reverse
A remodeling in those both with and without AF recurrence.80 It has
een proposed that atrial fibrosis induced by the ablation results in
eduction in LA size. A recent meta-analysis of studies involving
adiofrequency catheter ablation for AF indicates that LA volume
6 Curr Probl Cardiol, January 2012
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Cecreases in those without AF recurrence after ablation but not statisti-
ally significantly so in those with AF recurrence.82
Using the LGE-CMR technique previously described, McGann et al
valuated the effect of AF ablation on LA scarring.83 These authors
bserved a significant positive relationship between the quantity of
carring caused by the ablation and the subsequent freedom from AF.
hese findings provide potentially important insights into the mechanisms
f AF and the prediction of a favorable response to its ablation.
onclusion and Future Directions
Multimodality cardiac imaging has to date enabled a thorough under-
tanding of normal and pathologic LA structure and function. The
echanisms underlying their AF can be fully characterized and treatment
pproaches tailored accordingly. Moreover, observational research has
ielded potentially important insight into the predictive value of imaging
ndings for future cardiovascular outcomes. These studies give rise to
ntriguing hypotheses that imaging may improve the outcome of patients
ith, or at risk of, AF. Such hypotheses, with notable exceptions, remain
o be proven in the setting of randomized clinical trials. This level of
vidence would add significant weight to the incorporation of imaging
nto patient management guidelines and algorithms.
asood Akhtar: The authors describe some of the currently used techniques
or preprocedure anatomical delineation, intraprocedure catheter navigation,
nd postprocedure identification of possible complications. Significant ad-
ancement in these technologies is providing further help to physicians in
anaging this complex arrhythmia. 3D transesophageal and intracardiac
chocardiography are likely to be of significant benefit in the future. Caution
s, however, needed in interpreting some of the most commonly used
echniques during catheter ablation techniques, such as 3D-3D and 3D-2D
mage integration to help navigate catheters during the ablation procedures.
any of these techniques use the principle of rigid body registration, which
lthough ideal in a structure such as brain, could potentially cause significant
rrors of interpretation in a moving structure, such as heart, due to deformi-
ies created by cardiac cycle motion and respiration.
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